New Guidelines on Neuropsychiatric Symptoms in Huntington's New Guidelines on Neuropsychiatric Symptoms in Huntington's
New guidelines for the management of agitation, anxiety, apathy, psychosis, and sleep disorders in Huntington's disease patients have been published.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 8, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Lynn Program Helps New Mothers Struggling With Opioid Addiction
LYNN (CBS) – Recent research shows the opioid epidemic can be especially deadly for new mothers. When it comes to finding help, long-term options are not usually available. A unique program in Lynn is giving moms the kind of help they need. Jessica Cardinal found the help she needed at the Johnson Street residential treatment program. The 24-year-old recovering heroin addict is now slowly rebuilding her life. A mother of two, Jessica says her darkest days are unrecognizable. “It ended with me in a car shooting heroin with my kid in the back. And that, to me, was my rock bottom,” she recalled. “There...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 6, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Lynn Opioid Addiction opioid crisis Source Type: news

CIRM approves $6 million for UCI Researchers to study new treatment for Huntington's disease
(University of California - Irvine) Following a California Institute for Regenerative Medicine (CIRM) Independent Citizens Oversight Committee meeting held last week, University of California, Irvine (UCI) researchers learned they will receive $6 million in funding to support the continued development of a promising new treatment for Huntington's disease (HD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2019 Category: International Medicine & Public Health Source Type: news

Revolutionary microscopy technique allows scientists to better understand amyloid-based diseases such as Alzheimer's and Parkinson's
(Natural News) A new breed of powerful microscopes has enabled British researchers to make huge strides in the study of amyloid diseases. According to a Science Daily article, cryo-electron microscopes have enabled new discoveries about the proteins that cause Alzheimer’s, Huntington’s, and Parkinson’s diseases. These powerful instruments use electrons to view the shape of the samples.... (Source: NaturalNews.com)
Source: NaturalNews.com - February 3, 2019 Category: Consumer Health News Source Type: news

Expert-based clinical guidelines focus on behavioral symptoms in Huntington's disease
(IOS Press) Although Huntington's disease (HD) is traditionally thought of as a neurological disorder, behavioral symptoms are a common feature and frequently cause distress and difficulty to patients, family members, and other caregivers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news

Comparable rates of simulator sickness in Huntington's disease and healthy individuals - Jacobs M, van der Zwaan KF, Hart EP, Groeneveld GJ, Roos RAC.
OBJECTIVE Investigating driving competence with a simulator provides a controlled setting and has a high reproducibility. In addition, there is less risk of physical harm compared to on-road tests. A disadvantage of using simulators is the occurrence of s... (Source: SafetyLit)
Source: SafetyLit - January 29, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Gosport hospital deaths: 'My father’s life was ended by someone else'
David Huntington told BBC Panorama of his anger over his father’s death at the Gosport War Memorial Hospital. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 21, 2019 Category: Consumer Health News Source Type: news

Kettenbach LP Acquires Airway Metrics, LLC
Huntington Beach, CA —January 15, 2019—Management from Kettenbach LP and Airway Metrics LLC announced today the acquisition by Kettenbach LP of all business assets of Airway Metrics effective end of business February 28, 2019.Airway Metrics LLC has provided an effective product system to assist dentists in determining the correct vertical and protrusive dimensions needed in a bite to produce an optimum airway to manage OSA through dental professionally prescribed and delivered oral sleep appliances.Supported by a large number of experts in the field of Dental Sleep Medicine, Airway Metrics has become an essenti...
Source: Dental Technology Blog - January 16, 2019 Category: Dentistry Source Type: news

Sea slug study illuminates how mitochondria move
(Scripps Research Institute) Defects in the transport of cells' energy organelles are a suspected cause of diseases including Alzheimer's, ALS, Huntington's and Parkinson's. A new study reveals the genetics behind mitochondrial shifts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 16, 2019 Category: International Medicine & Public Health Source Type: news

Speeding up genetic diagnosis of Huntington's disease
(Swiss National Science Foundation (SNSF)) Elongated segments of DNA cause Huntington's disease and certain other disorders of the brain. Researchers funded by the SNSF have developed a method to determine the length of the mutated genes quickly and easily. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2019 Category: International Medicine & Public Health Source Type: news

Fire chief's approach to opioid crisis has big impact
We're kicking off our new TED Talks partnership with Jan Rader, who's hailed for her efforts in Huntington, West Virginia (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 2, 2019 Category: Consumer Health News Source Type: news

Huntington's Antisense Therapy Enters Phase III
(MedPage Today) -- Other ways to halt mutant huntingtin also emerge (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - December 26, 2018 Category: Neurology Source Type: news

Antisense Therapy Shows Promise in Huntington's
(MedPage Today) -- First human trial of huntingtin-lowering drug appears safe, well tolerated (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - December 26, 2018 Category: Neurology Source Type: news

Autophagy and mitochondria: Targets in neurodegenerative disorders
(Bentham Science Publishers) Cellular homeostasis depends on the timely clearance of damaged cellular organelles and proteins via pathways including autophagy. Mitochondria and mitochondrial autophagy play a vital role in cellular health and failure of these pathways can have a devastating effect on cellular homeostasis. Here, the researchers review the involvement of mitochondrial and autophagy dysfunction in neurodegenerative disorders specifically focusing on Alzheimer's, Parkinson's and Huntington's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news

Pitt-led research describes how neurons could disconnect from each other in Huntington's disease
(University of Pittsburgh Schools of the Health Sciences) Newly described mechanism called 'neuritosis' could play an important role in normal brain development, aging and neurodegenerative disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 24, 2018 Category: International Medicine & Public Health Source Type: news

The brain's support cells show defective development in Huntington's disease
(University of Copenhagen The Faculty of Health and Medical Sciences) The neurological disorder Huntington's disease causes behavioral and motor changes, which among other things are a result of dysfunctional maturation or formation of glial cells, the brain's support cells, researchers from the University of Copenhagen demonstrate in a new study based on mice trials. The researchers' long-term goal is to be able to use the research results to develop a treatment for Huntington's disease using glial cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 21, 2018 Category: Biology Source Type: news

Study Confirms Central Role of Brain ’s Support Cells in Huntington’s, Points to New Therapies
New research gives scientists a clearer picture of what is happening in the brains of people with Huntington ’s disease and lays out a potential path for treatment. The study, which appears today in the journal Cell Stem Cell, shows that support cells in the brain are key contributors to the disease. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - December 14, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Gait, balance, and falls in Huntington disease - Vuong K, Canning CG, Menant JC, Loy CT.
Huntington disease (HD) is an autosomal-dominant, progressive, neurodegenerative disorder, characterized by involuntary movements and other motor impairments, cognitive/behavioral symptoms, and psychiatric disorders. Gait and balance impairments and falls ... (Source: SafetyLit)
Source: SafetyLit - December 3, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Woman who inherited fatal illness to sue doctors in groundbreaking case
Legal action over non-disclosure of father ’s Huntington’s disease could lead to huge changes in patient confidentialityLawyers are bringing a case against a London hospital trust that could trigger major changes to the rules governing patient confidentiality. The case involves a woman who is suing doctors because they failed to tell her about her father ’s fatal hereditary disease before she had her own child.The woman discovered – after giving birth – that her father carried the gene for Huntington’s disease, a degenerative, incurable brain condition. Later she found out she had inheri...
Source: Guardian Unlimited Science - November 25, 2018 Category: Science Authors: Robin McKie Science Editor Tags: Huntington's disease UK news Science Genetics Biology Law Doctors Health Society Source Type: news

C-Path, CHDI and CDISC announce therapeutic area user guide for Huntington's Disease
(Critical Path Institute (C-Path)) The Huntington's Disease Regulatory Science Consortium, launched in March 2018 by the Critical Path Institute and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium, announce the open availability of a newly developed Huntington's Disease Therapeutic Area User Guide. The guide has been developed to describe the most broadly utilized clinical concepts for data acquisition and analysis in Huntington's disease clinical studies using the CDISC standard format. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2018 Category: International Medicine & Public Health Source Type: news

Knocking On Doors To Get Opioid Overdose Survivors Into Treatment
Within days of an OD from opioids or other drugs, users in Huntington, W.Va., are visited by a quick-response team at home, the hospital or in jail. Reversing an OD is just recovery's first step.(Image credit: Sarah McCammon/NPR) (Source: NPR Health and Science)
Source: NPR Health and Science - October 24, 2018 Category: Consumer Health News Authors: Sarah McCammon Source Type: news

Predictors of simulated driving performance in Huntington's disease - Jacobs M, Hart EP, Mejia Miranda Y, Groeneveld GJ, van Gerven JMA, Roos RAC.
BACKGROUND: As the disease progresses, patients with Huntington's disease (HD), an inherited neurodegenerative disorder, become less independent in their daily life activities and have to consider if they can still drive a car. For most patients, the decis... (Source: SafetyLit)
Source: SafetyLit - October 9, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Penn researchers: Class of neurological disorders share 3D genome folding pattern
(University of Pennsylvania) Researchers at the University of Pennsylvania have found a new common thread linking nearly all of the trinucleotide repeat expansion diseases, which include ALS, Huntington's Disease and Fragile X Syndrome, involving the complicated 3D patterns that the DNA is folded into in order to fit in the nucleus of the cell. Nearly all of the short tandem repeats known to grow unstable in disease are located at the boundaries that separate neighboring folded domains. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Improving Huntington's disease detection
(Source: ScienceNOW)
Source: ScienceNOW - September 13, 2018 Category: Science Authors: Maroso, M. Tags: twis Source Type: news

Brain ’s support cells may play a central role in repetitive behaviors related to OCD
Repetitive behavior disorders are relatively common. One of the best known in this family is obsessive compulsive disorder, or OCD, which affects more than2 percent of the U.S. population. Existing treatments, often medications, may not bring adequate relief for about half of those with the disorder.UCLA researchers have uncovered some of the basic brain mechanisms behind repetitive behavior, which may ultimately lead to new ways to treat psychiatric disorders, including OCD, at their root.The study, published in the journal  Neuron, was led by Baljit Khakh, professor of physiology and neurobiology at UCLA.Khakh and h...
Source: UCLA Newsroom: Health Sciences - September 7, 2018 Category: Universities & Medical Training Source Type: news

Huntington's disease: the price paid for our big brains? – Science Weekly podcast
This degenerative illness has a few genetic quirks which scientists believe could cause secondary health benefits. Emerging research suggests that people with Huntington ’s are less sickly, don’t get cancer as often and even have more brain cells.Hannah Devlin investigates.Subscribe and review onAcast,Apple Podcasts,Soundcloud,Audioboom andMixcloud. Join the discussion onFacebook andTwitterThe gene responsible for Huntington ’s was identified 25 years ago. Patients with an especially long Huntington’s gene are more likely to develop this neurodegenerative disease.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 24, 2018 Category: Science Authors: Presented by Hannah Devlin and produced by Graihagh Jackson Tags: Neuroscience Huntington's disease Evolution Source Type: news

New CRISPR technique skips over portions of genes that can cause disease
(University of Illinois at Urbana-Champaign) In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell's internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. Such targeted editing could one day be useful for treating genetic diseases caused by mutations in the genome, such as Duchenne's muscular dystrophy, Huntington's disease or some cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 16, 2018 Category: International Medicine & Public Health Source Type: news

PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington ’s disease
Roche today announced that the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) designation for the company ’s investigational medicine RG6042 (formerly known as IONIS-HTTRx) for the treatment of people with Huntington’s disease (HD). (Source: Roche Media News)
Source: Roche Media News - August 3, 2018 Category: Pharmaceuticals Source Type: news

PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington ’s disease
Roche today announced that the European Medicines Agency (EMA) has granted PRIME (PRIority MEdicines) designation for the company ’s investigational medicine RG6042 (formerly known as IONIS-HTTRx) for the treatment of people with Huntington’s disease (HD). (Source: Roche Investor Update)
Source: Roche Investor Update - August 3, 2018 Category: Pharmaceuticals Source Type: news

Researchers discover system that could reduce neurodegeneration in Huntington's disease
(University of Cologne) The neuroscientist Dr David Vilchez and his team at CECAD, the University of Cologne's Cluster of Excellence for Aging Research, have made an important step towards understanding the mechanisms that cause the neurodegenerative disorder Huntington's disease. Particularly, they identified a system blocking the accumulation of toxin protein aggregates, which are responsible for neurodegeneration. The results have now been published in the journal 'Nature Communications'. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2018 Category: International Medicine & Public Health Source Type: news

New system can identify drugs to target 'undruggable' enzymes critical in many diseases
(Medical Research Council) A new drug discovery system allows scientists to specifically target members of an important family of enzymes, called phosphatases, which were previously considered mostly 'undruggable'. The study, published in Cell, demonstrated the capabilities of the new system by identifying a molecule that could successfully target a phosphatase to reduce the accumulation of Huntington's disease-associated proteins in the brains of mice. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 26, 2018 Category: International Medicine & Public Health Source Type: news

IMI Launches New Antimicrobial Resistance Accelerator Programme as Part of Latest Calls for Proposals
A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders (e.g. Alzheimer's disease, Parkinson's disease, Huntington's disease, major depression) and immune-mediated diseases (e.g. rheumatoid arthritis and lupus as well as inflammatory bowel diseases such as Crohn's and colitis, and skin diseases like dermatitis and psoriasis). (Source: eHealth News EU)
Source: eHealth News EU - July 18, 2018 Category: Information Technology Tags: Featured Open Calls Source Type: news

Complex brain circuitry revealed using new single-cell sequencing technology
(The Translational Genomics Research Institute) Researchers at TGen and Circuit Therapeutics Inc. are studying the brain's striatum, which not only is responsible for controlling how we move, but also contributes to the brain's decision-making and the initiation of action. Nearly 95 percent of the cells that make up the striatum are known as medium spiny neurons (MSN), which is associated with many psychiatric and neurodegenerative diseases, including Parkinson's disease, Huntington's disease, schizophrenia, drug addition and ADHD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 5, 2018 Category: International Medicine & Public Health Source Type: news

Evaluating depression and suicidality in tetrabenazine users with Huntington disease - Schultz JL, Killoran A, Nopoulos PC, Chabal CC, Moser DJ, Kamholz JA.
OBJECTIVE: To determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suicidal ideation. METHODS: In this retrospective cross-sectional study of the Enroll-HD database, we used multiple logistic regr... (Source: SafetyLit)
Source: SafetyLit - June 26, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Nuclear Engineering expert honored by Health Physics Society
(Rensselaer Polytechnic Institute) Nuclear engineering expert George Xu, the Edward E. Hood Jr. Endowed Chair of Engineering at Rensselaer Polytechnic Institute, has been selected to receive the Distinguished Scientific Achievement Award of the Health Physics Society. The award will be given during the 2018 Annual Meeting in Cleveland, Ohio, July 15-19 at the Huntington Cleveland Convention Center. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 22, 2018 Category: Biology Source Type: news

Researchers find important new piece in the Huntington's disease puzzle
(University of Copenhagen The Faculty of Health and Medical Sciences) In a new study, researchers from the University of Copenhagen have discovered a hitherto unknown error in the transport of glutamine between astrocytes and neurons in the brain of mice with Huntington's disease. At the same time, it is a relevant area on which to focus the effort of developing a future treatment for the disease, the researchers believe. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2018 Category: International Medicine & Public Health Source Type: news

Do RA and Huntington's Disease Share Epigenetic Link?
(MedPage Today) -- Study using cells from RA joints identified an association (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - May 26, 2018 Category: Neurology Source Type: news

Exposures to single-use detergent sacs reported to a statewide poison control system, 2013-2015 - Vohra R, Huntington S, Fenik Y, Phan D, Ta N, Geller RJ.
BACKGROUND: Single-use detergent sacs (SUDSs) represent a relatively new household hazard to children. Brand differences and packaging changes may contribute to differential risks with accidental exposure. We sought to identify high-risk features from SUDS... (Source: SafetyLit)
Source: SafetyLit - May 18, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Study links rheumatoid arthritis, Huntington's disease
Researchers have found a genetic link between rheumatoid arthritis and Huntington's disease, which shows promise of new treatment for both conditions. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 15, 2018 Category: Consumer Health News Source Type: news

Joint resolution: A link between Huntington's disease and rheumatoid arthritis
(University of California - San Diego) Using new analytic tools, researchers at University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have decoded the epigenetic landscape for rheumatoid arthritis (RA), a common autoimmune disease that affects more than 1.3 million Americans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 15, 2018 Category: International Medicine & Public Health Source Type: news

Companies to use data in battle against Parkinson's, Alzheimer's, ALS
Morrisville-based contract research organization Worldwide Clinical Trials and Roivant-backed health care technology company Datavant are partnering to take on neurodegenerative diseases. Some of the most common neurodegenerative diseases include Parkinson's, Alzheimer's, Huntington's and amyotrophic lateral sclerosis, or ALS. According to Worldwide and Datavant, the most common neurodegenerative diseases cost the U.S. close to $800 billion annually.  Through the new partnership, Worldwide and… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 8, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news

More Positive Results Released for Novel Huntington's Drug More Positive Results Released for Novel Huntington's Drug
The novel antisense oligonucleotide known as IONIS-HTTRx is safe and well tolerated and'has the potential to provide disease-modifying benefits'in Huntington's disease, say researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Antisense Therapy Shows Promise in Huntington's
(MedPage Today) -- First human trial of huntingtin-lowering drug appears safe, well tolerated (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 25, 2018 Category: Neurology Source Type: news

In Huntington's disease, heart problems reflect broader effects of abnormal protein
(Children's Hospital of Philadelphia) Researchers investigating a key signaling protein in Huntington's disease describe deleterious effects on heart function, going beyond the disease's devastating neurological impact. By adjusting protein levels affecting an important biological pathway, the researchers improved heart function in experimental animals, shedding light on the biology of this fatal disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2018 Category: Biology Source Type: news

Dozens arrested in drug bust in Huntington, West Virginia
A federal prosecutor has announced a major drug trafficking bust in Huntington, West Virginia (Source: ABC News: Health)
Source: ABC News: Health - April 17, 2018 Category: Consumer Health News Tags: Health Source Type: news

Scientists find excess mitochondrial iron, Huntington's disease link
(University of Wyoming) The research identifying a pathway for Huntington's disease helps lay the foundation for developing drug therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2018 Category: International Medicine & Public Health Source Type: news

Perseveration and suicide in Huntington's disease - Roman OC, Stovall J, Claassen DO.
BACKGROUND: Huntington's disease (HD) patients are at significantly higher risk of suicidal behavior, and associated cognitive and behavioral factors play an important role. Impulsivity is commonly thought to be a risk factor, but does not completely accou... (Source: SafetyLit)
Source: SafetyLit - April 7, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

National equity investment will help firm expand 24-7 home-based doctor visits
The company, based in Huntington Beach, Calif., first entered the market in 2015 through a contract with BlueCross BlueShield of Western New York. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 6, 2018 Category: Biotechnology Authors: Tracey Drury Source Type: news

National equity investment will help firm expand 24-7 home-based doctor visits
The company, based in Huntington Beach, Calif., first entered the market in 2015 through a contract with BlueCross BlueShield of Western New York. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 6, 2018 Category: Health Management Authors: Tracey Drury Source Type: news

Landmark Health plans N.C. entrance through partnership with Blue Cross
Huntington Beach, Calif.-based Landmark Health is planning its entrance to the Tar Heel State through a new partnership with Blue Cross and Blue Shield of North Carolina. “We’re a risk-based provider group that cares for chronic, complex populations,” Jessica Diaz, senior director of brand and marketing at Landmark, said Thursday. “We partner with health plans and identify subsets of their population that really needs more care.” The new partnership with the Blue Cross of N.C. will see… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 30, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news